Our Story



Founded in 2021, LexBio pioneers a new era in drug discovery by harnessing the power of Artificial Intelligence (AI) to revolutionize the process of identifying and developing life-changing medicines. Our mission is to expedite the identification of novel therapeutic candidates with unparalleled efficiency and ingenuity.

2023 Lenovo Star Entrepreneurship

2022 Jinji Lake Partner Program

2022 China Innovation and Entrepreneurship Competition, Excellent Enterprise.

2021 Suzhou Industrial Park  Science and Technology Entrepreneurship Leading Talent

2021 “Jinji Lake Entrepreneurship Competition” Second Place

2021 Suzhou  Innovation and Entrepreneurship Leading Talent

Advisory Board



Dr. Dajun Yang

Founder& Chief Executive Officer of Ascentage Pharma



Dr. Jinbo Lee

20+ years of senior executive and entrepreneurship experience


Dr. Ling Hua

Formerly Research Head Dupont

Teams



Our interdisciplinary teams in Suzhou, Shanghai and Boston consist of AI experts, data scientists, software engineers, biologists, computational and medicinal chemists.

Partnerships

SH 688202
SH 688202
SH 603259/ HK 02359
SH 603259/ HK 02359
DUS ESF0
DUS ESF0
SZ 300759/ HK 03759
SZ 300759/ HK 03759
Investors
E-mail:
contact@lexbiotx.com
Address:
328 Xinghu Road, Suzhou Industrial Park, China